Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$44.67M
Expense Ratio	1.49%
PE Ratio	n/a
Shares Out	1.95M
Dividend (ttm)	$0.70
Dividend Yield	3.07%
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	243,827
Open	23.49
Previous Close	23.31
Day's Range	22.86 - 23.57
52-Week Low	12.18
52-Week High	31.19
Beta	0.59
Holdings	12
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

268.10% of assets

Name	Symbol	Weight
ELI LILLY & CO SWAP MS	n/a	58.36%
ELI LILLY & CO SWAP Cantor - L	n/a	25.69%
ELI LILLY & CO SWAP MAREX	n/a	25.66%
ELI LILLY & CO SWAP CS	n/a	25.05%
US DOLLARS	n/a	24.86%
ELI LILLY AND COMPANY-SWAP-NBCB-L	n/a	24.70%
United States Treasury Bills 0%	B.0 08.27.26	24.10%
LLY SWAP NOMURA	n/a	23.95%
ELI LILLY & CO SWAP BMO	n/a	18.48%
OTHER ASSETS AND LIABILITIES	n/a	17.25%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.70417	Dec 31, 2025

Performance

LLYX had a total return of 70.57% in the past year, including dividends. Since the fund's inception, the average annual return has been -0.21%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Sep 14, 2026

Data Sources Report a data error